Privately held On-X® Life Technologies Inc. (On-X LTI) announced today that it will present the results of the PROACT1 clinical trial of the CE-marked On-X® Plus 1.5™ Aortic Heart Valve during the upcoming scientific meeting of the American Association for Thoracic Surgery (AATS) in Toronto, April 27-30.
Help employers find you! Check out all the jobs and post your resume.
